Muscle-Sparing Effect Of Human Chorionic Gonadotropin (hCG) During a Very Low Calorie Diet (VLCD)
Completed · Phase 1/Phase 2 · Has a placebo group
Conditions studied: HCG
In brief
Subjects are female patients, randomized to HCG group or placebo group, during a prospective trial, in order to determine the significance, if any, of HCG on maintaining muscle mass during a very low calorie diet in order to demonstrate the potential significance of HCG administration on preserving lean body mass while losing weight.
Key facts
- Study ID
- NCT02427529
- Run by
- Dr. Emma's Corporation
- People needed
- 59
- Starts
- 2011-05-01
- Expected to finish
- 2012-12-01
- Last updated by the study team
- 2015-04-28
Who can join
Age: 18 and older, up to 65. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Body Mass Index (BMI) greater than 30,
- Female,
- good health
You may not qualify if…
- complex medical history,
- thyroid disease,
- BMI less than 30,
- psychological instability or history of eating disorder
Where it is running
- Dr. Emma's Corporation — Colts Neck, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.